OPPORTUNITIES TO OPTIMIZE ANTIEPILEPTIC THERAPY WITH USE OF PHARMACOGENETIC BIOMARKERS

OPPORTUNITIES TO OPTIMIZE ANTIEPILEPTIC THERAPY WITH USE OF PHARMACOGENETIC BIOMARKERS

Pharmacogenetics allows to determine the cause of the ineffectiveness of drug therapy for certain groups of people who do not respond to treatment or exhibiting an inadequate response to a standard dose of the drug. Pharmacogenetic test can predict the speed and features of a metabolism of antiepile...

Full description

Bibliographic Details
Main Authors: T. V. Dokukina, M. V. Makhrov, I. V. Gaidukevich, A. A. Gilep, T. S. Golubeva, F. P. Khlebokazov, N. N. Misyuk, P. P. Korolevich
Format: Article
Language:Russian
Published: IRBIS LLC 2016-05-01
Series:Эпилепсия и пароксизмальные состояния
Subjects:
pharmacogenetics
anticonvulsants
epilepsy
drug-resistance
dna
genotyping
Online Access:https://www.epilepsia.su/jour/article/view/10

Internet

https://www.epilepsia.su/jour/article/view/10

Similar Items